Paucity of retinoic acid receptor alpha (RARα) nuclear immunostaining in gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression

Journal of Neuro-Oncology

Volumn 41, Issue 1, 1999, Pages 31-42

  Kleinschmidt DeMasters, B K ^a   Orr, Elizabeth A ^a   Savelieva, Elena ^a   Owens, Geoffrey C ^a   Kruse, Carol A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Adhesion molecule; Astrocytoma; Brain tumors; Glioblastoma multiforme; Retinoic acid; Vitamin A

Indexed keywords

MONOCLONAL ANTIBODY; NERVE CELL ADHESION MOLECULE; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; CELL MIGRATION; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MELANOMA; MENINGIOMA; METASTASIS; OLIGODENDROGLIOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BRAIN; BRAIN NEOPLASMS; CELL NUCLEUS; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGEAL NEOPLASMS; MENINGIOMA; NEURAL CELL ADHESION MOLECULES; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032958499     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006162211296     Document Type: Article

References (39)

1. Rodts GE, Black KL: Trans retinoic acid inhibits in vivo tumour growth of C6 glioma in rats: Effect negatively influenced by nerve growth factor. Neurol Res 16: 184-186, 1994
2. Yung WKA, Lotan R, Iee P, Lotan D, Steck PA: Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells. Cancer Research 49: 1014-1019, 1989
3. Rutka JT, DeArmond SJ, Giblin J, McCulloch JR, Wilson CB, Rosenblum ML: Effect of retinoids on the proliferation, morphology and expression of glial fibrillary acidic protein of an anaplastic astrocytoma cell line. Int J Cancer 42: 419-427, 1988
4. Castaigne S, Chomienne C, Daniel MT, Bellarini P, Berger R, Fenaux P, Degos L: All trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia I. Clinical results. Blood 76: 1704-1709, 1990
5. Alcalay M, Zangrilli D, Pandolfi PP, Longo L, Mencarelli A, Giacomucci A, Roechi M, Biondi A, Rambaldi A, Lo Coco F, Diveno D, Donti E, Grignani F, Pelicci PG: Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor locus. Proc Nat Acad Sci 88: 1977-1981, 1991
6. Kaba SE, Kyritsis AP, Conrad C, Gleason MJ, Newman R, Levin VA, Yung WKA: The treatment of recurrent cerebral gliomas with all trans retinoic acid (tretinoin). J Neuro-Oncology 34: 145-151, 1997
7. Phuphanich S, Scott C, Fischbach AJ, Langer C, Yung WKA: All trans retinoic acid: a phase II radiation therapy oncology group study (RTOG 91-13) in patients with recurrent malignant astrocytoma. J Neuro-Oncology 34: 193-200, 1997
8. Defer G-L, Adle-Biassette H, Ricolfi F, Martin L, Authier F-J, Chomienne C, Degos L, Degos J-D: All trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications. J Neuro-Oncology 34: 169-177, 1997
9. Franklin WA: Retinoids: Old data and new. Lung Cancer Institute of Colorado, Winter/Spring Newsletter, 1992, pp 10-11, 20.
10. Husmann M, Görgen I, Weisgerber C, Bitter-Suermann D: Up-regulation of embryonic NCAM in an EC cell line by retinoic acid. Develop Biol 136: 194-200, 1989
11. Edelman GM: Cell adhesion molecules. Science 219: 450-457, 1983
12. Albelda SM: Biology of Disease: Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68: 4-15, 1993
13. Couldwell WT, de Tribolet N, Antel JP, Gauthier T, Kuppner MC: Adhesion molecules and malignant gliomas: implications for tumorigenesis. J Neurosurg 76: 782-791, 1992
14. Owens GC, Orr EA, Kleinschmidt-DeMasters BK, Muschel RJ, Berens ME, Kruse CA: Over-expression of a transmembrane isoform of neural cell adhesion molecule (NCAM) alters the invasiveness of rat CNS-1 glioma. Cancer Res. 58: 2020-2028, 1998
15. Figarella-Branger DF, Durbec PL, Rougon GN: Differential spectrum of expression of neural cell adhesion molecule isoforms and L1 adhesion molecules on human neuroectodermal tumors. Cancer Res 50: 6364-6370, 1990
16. Patel K, Bourne S, Coakham H, Kemshead JT: Expression of the neural cell adhesion molecule in human brain tumours. Biochem Soc Transact 18: 264, 1990
17. Kleinschmidt-DeMasters BK, Conway DR, Franklin WA, Lillehei KO, Kruse CA: Neural cell adhesion molecule expression in human pituitary adenomas. J Neuro-Oncology 25: 205-213, 1995
18. Walsh FS, Doherty P: Structure and function of the gene for neural cell adhesion molecule. The Neurosciences 3: 271-284, 1991
19. Chorny JA, Kruse CA, Kleinschmidt-DeMasters BK, Garza-Williams S, Conway DR, Gaub M-P, Rochette-Egly C, Franklin WA: Immunohistochemical study of the retinoic acid receptor in normal versus neoplastic human tissues. Appl Immunohistochem 3(1): 64-71, 1995
20. Paasivuo R, Saksela E: Non-specific binding of mouse immunoglobulins by swollen-bodied astrocytes - a potential source of confusion in human brain immunohistochemistry. Acta Neuropathol 59: 103-108, 1983
21. Spanjaard RA, Ikeda M, Lee PJ, Charpentier B, Whin WW, Eberlein TJ: Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role of RARgamma in induction of differentiation and apoptosis of S91 melanoma cells. J Biol Chem 272(30): 18990-18999, 1997
22. Schadendorf D, Kern MA, Artuc M, Pahl HL, Rosenbach T, Fichtner I, Nurnberg W, Stuting S, von Stebut E, Worm M, Makki A, Jurgovsky K, Kolde G, Henz BM: Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol 135(6 Pt 2): 1889-1889, 1996
23. Triozzi PL, Walker MJ, Pellegrini AE, Dayton MA: Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma. Cancer Invest 14(4): 293-298, 1996
24. Melino G, Thiele CJ, Knight RA, Piacentini M: Retinoids and the control of growth/death decisions in human neuroblastoma cell lines. J Neuro-Oncol: 31(1-2): 65-83, 1997
25. Ashwell JD: When complex worlds collide: retinoic acid and apoptosis. Cell Death Differ. 5: 1-3, 1998
26. Szondy Z, Reichert U, Fesus L: Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors. Cell Death Differ 5: 4-10, 1998
27. Nagy L, Thomazy VA, Heyman RA, Davies PJA: Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ 5: 11-19, 1998
28. Mattei M-G, Riviere M, Krust A, Ingvarsson S, Vennstrom B, Islam MQ, Levan G, Kastner P, Zelent A, Chambon P, Szpierer J, Szpierer C: Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse and rat genomes. Genomics 10: 1061-1069, 1991
29. Hoffman S, Edelman GM: Kinetics of homophilic binding by embryonic and adult forms of the neural cell adhesion molecule. Proc Natl Acad Sci USA 80: 5762-5766, 1983
30. Aletsee-Ufrecht MC, Langley OK, Gratzl M: NCAM expression in endocrine cells. Acta Histochemica 38: 45-50, 1990
31. Langley OK, Aletsee-Ufrecht MC, Grant NJ, Gratzl M: Expression of the neural cell adhesion molecule NCAM in endocrine cells. J Histochem Cytochem 37: 781-791, 1989
32. Aletsee-Ufrecht MC, Langley K, Gratzl O, Gratzl M: Differential expression of the neural cell adhesion molecule NCAM 140 in human pituitary tumors. FEBS Lett 272: 45-49, 1990
33. Conway DR, Kleinschmidt-DeMasters BK, Franklin WA, Gaub MP, Rochette-Egly C, Kruse CA: Expression of neural cell adhesion molecule and retinoic acid receptor in normal brain and in glial and non-glial brain tumors. Mol Biol Cell 3: 216a (abstr), 1992
34. Molenaar WM, de Leij L, Trojanowski JQ: Neuroectodermal tumors of the peripheral and the central nervous system share neuroendocrine N-CAM-related antigens with small cell lung carcinomas. Acta Neuropathol 83: 46-54, 1991
35. Edvardsen K, Brünner N, Spang-Thomsen M, Walsh FS, Bock E: Migration of tumor cells. Int J Dev Neurosci 11 (5): 681-690, 1993
36. Edvardsen K, Chen W, Rucklidge G, Walsh FS, Öbrink B, Bock E: Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. Proc Natl Acad Sci USA 90: 11463-11467, 1993
37. Kruse CA, Merchant RE: Cellular therapy of brain tumors: Clinical trials. In: Kornblith PK, Walker MD (eds) Advances in Neuro-Oncology II. Futura Publishing Company, Inc., Armonk, NY, 1997, p 487
38. Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH: Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol 146(12): 4421-4426, 1991
39. Nitta T, Yagita H, Sato K, Okumura K: Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction. J Exp Med 170: 1757-1761, 1989